Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non-Small-cell Lung Cancer
晚期非小细胞肺癌患者接受高剂量培美曲塞、吉西他滨和贝伐单抗联合治疗的II期临床试验
期刊:Clinical Lung Cancer
影响因子:3.3
doi:10.1016/j.cllc.2016.11.019
Schneider, Bryan J; Kalemkerian, Gregory P; Gadgeel, Shirish M; Valdivieso, Manuel; Hackstock, Deborah M; Chen, Wei; Heilbrun, Lance K; Ruckdeschel, John C; Wozniak, Antoinette J
